Top Markets
#1 Seeker Seeker +49.88%
#2 Helium Helium +43.34%
#3 TENDIES TENDIES +31.18%
#4 Pons Pons +26.01%
#5 pipedog pipedog +21.90%
#6 Zylo Ecosystem Zylo Ecosystem +21.65%
#7 Bounce Bounce +19.30%
#8 UnifAI Network UnifAI Network +18.93%
#9 ZKsync ZKsync +14.73%
#10 Zora Zora +14.06%
Coin of the day
Seeker Seeker
설정
언어
한국어
통화
USD
테마
Poseida Therapeutics, Inc. Poseida Therapeutics, Inc.

Poseida Therapeutics, Inc.

PSTX
주식 순위 #10560
Poseida Therapeutics, Inc., a San Diego-based clinical-stage biopharmaceutical... Poseida Therapeutics, Inc., a San Diego-based clinical-stage biopharmaceutical firm established in 2014, is dedicated to advancing novel therapeutic solutions for conditions with significant unmet medical needs. Its pipeline prominently features several advanced cell therapies. For instance, P-PSMA-101, an autologous CAR-T cell therapy, is currently undergoing Phase I clinical trials for individuals battling metastatic castrate-resistant prostate cancer (mCRPC). Additionally, Poseida is progressing two other CAR-T candidates through Phase I: P-BCMA-ALLO1 targets relapsed/refractory multiple myeloma, while P-MUC1C-ALLO1 is designed to address a variety of solid tumors, such as breast, ovarian, and other epithelial-derived malignancies. The company is further exploring allogeneic (off-the-shelf) CAR-T approaches with candidates like P-CD19CD20-ALLO1, aimed at B cell malignancies and certain autoimmune conditions, and P-BCMACD19-ALLO1, which is in preclinical development for multiple myeloma. Another allogeneic CAR-T, P-PSMA-ALLO1, is also being developed for mCRPC. Beyond cell therapies, Poseida's portfolio includes clinical-stage liver-directed gene therapies, specifically P-OTC-101 and P-FVIII-101, alongside other exploratory allogeneic dual CAR candidates. Collaborative efforts include a research and licensing agreement with Takeda Pharmaceutical Company Limited.
주가
$9.50
마지막 동기화: 2025-01-08
시가총액
$819.52M
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 Poseida Therapeutics, Inc. (PSTX)

카테고리

Healthcare
Poseida Therapeutics, Inc. (PSTX)의 주가 이력
최고 종가: $9.50 (2025-01-01 기준)

최저 종가: $14.51 (2020-07-01 기준)
Poseida Therapeutics, Inc.의 주가 이력 (2020 ~ 2026)
연간 주가 성과
연도 성과
2025 0.49%
2024 201.20%
2023 -41.30%
2022 -23.11%
2021 -33.50%
2020 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $542.09 38.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 44.13%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.53 -12.70%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.18 473.58%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $759.27 7.20%
CH